E. Reisner, S. J. Lippard
FULL PAPER
OCH3), 3.63 (s, 6 H, CO2CH3) ppm. 13C NMR (300 MHz, CDCl3, 7.53 (t, J = 8.4 Hz, 2 H, HAr), 7.42–7.36 (m, 18 H, HAr), 7.07 (s, 2
20 °C): δ = 169.2 (CO2), 149.2 (CAr), 141.9 (CAr), 141.5 (CAr), 131.6
(CAr), 131.4 (CAr), 130.9 (CAr), 130.7 (CAr), 130.2 (CAr), 128.6
(CAr), 127.7 (CAr), 122.6 (CAr), 119.0 (CAr), 114.1 (CAr), 92.4
H, HAr), 3.96 (s, 6 H, OCH3), 3.40 (s, 6 H, CO2CH3) ppm. 13C
NMR (500 MHz, CDCl3, 20 °C): δ = 169.9 (CO2), 149.3 (CAr),
140.7 (CAr), 140.7 (CAr), 140.6 (CAr), 139.8 (CAr), 132.9 (CAr),
(CϵC), 89.2 (CϵC), 56.2 (OCH3), 52.2 (CO2CH3) ppm. FTIR 131.7 (CAr), 129.7 (CAr), 129.4 (CAr), 128.9 (CAr), 128.7 (CAr),
(KBr): ν = 2941 (m), 2918 (m), 2849 (w) [ν(C–H)]; 2205 (w)
128.6 (CAr), 128.5 (CAr), 127.8 (CAr), 122.9 (CAr), 119.0 (CAr),
˜
[ν(CϵC)]; 1726 (s) [ν(C=O)] cm–1. ESI-MS (MeOH): calcd. for [M
+ Na]+ 629.2; found 629.2. C40H30O6 (606.66): calcd. C 79.19, H
4.98; found C 78.54, H 5.03.
114.2 (CAr), 92.3 (CϵC), 89.4 (CϵC), 56.3 (OCH3), 52.1 (CO2CH3)
ppm. FTIR (KBr): ν = 2961 (m), 2945 (m) [ν(C–H)]; 2206 (w)
˜
[ν(CϵC)]; 1729 (s) [ν(C=O)] cm–1. ESI-MS (MeOH): calcd. for [M
+ Na]+ 781.3; found 781.3.
4,5-Bis[2-(2Ј-carboxybiphenyl-4-yl)ethynyl]veratrole, DEV-
(biphCO2H)2 (6b): A portion of DEV(biphCO2Me)2 (6a) (0.600 g,
0.99 mmol) and anhydrous lithium iodide (2.00 g, 15.0 mmol) were
dissolved in anhydrous pyridine (35 mL) in a sealed pressure tube
inside a glove box. The reaction mixture was heated at 110 °C un-
der protection of light (Al foil) for 6 d. After cooling to room tem-
perature, the dark solution was quenched with water (200 mL).
Then CHCl3 (150 mL) was added and the aqueous phase acidified
with 4 HCl to pH = 1. The acidic aqueous phase was washed
with CHCl3 (100 mL), and the combined organic phases were
washed with water (2ϫ150 mL), dried with MgSO4, filtered, and
the solvents evaporated to dryness. The product was washed with
pentane and dried under high vacuum. Yield 0.320 g (56%). 1H
NMR (300 MHz, CDCl3, 20 °C): δ = 11.11 (br. s, 2 H, CO2), 7.99
(d, J = 8.5 Hz, 2 H, HAr) 7.64–7.57 (m, 6 H, HAr), 7.49–7.44 (m,
4 H, HAr), 7.37 (d, J = 8.4 Hz, 4 H, HAr), 7.08 (s, 2 H, HAr), 3.97
(s, 6 H, OCH3) ppm. 13C NMR (300 MHz, CDCl3, 20 °C): δ =
175.2 (CO2), 149.3 (CAr), 142.6 (CAr), 140.8 (CAr), 132.6 (CAr),
131.7 (CAr), 131.2 (CAr), 131.1 (CAr), 129.7 (CAr), 128.7 (CAr),
127.8 (CAr), 122.7 (CAr), 119.9 (CAr), 113.4 (CAr), 92.6 (CϵC), 88.8
(CϵC), 56.3 (OCH3) ppm.
4,5-Bis{2-[6-(methoxycarbonyl)pyrid-3-yl]ethynyl}veratrole,
DEV(PICMe)2 (8): Solid [Pd(PPh3)4] (0.27 g, 10 mol-%) was added
to a deoxygenated solution of 4,5-diethynylveratrole (1) (0.430 g,
2.31 mmol), and methyl 5-bromo-2-picolinate (1.10 g, 5.09 mmol)
in Et3N (5.0 mL) and THF (25 mL). The yellow solution was
heated at 60 °C for 36 h. The reaction mixture with some yellow
precipitate was cooled to room temperature, concentrated to dry-
ness, and dissolved in CHCl3 (150 mL). The organic phase was
washed with aq. NH4Cl (150 mL), which was dried with Na2SO4,
filtered, and the solvents were evaporated to dryness. The product
was purified by column chromatography (CHCl3/diethyl ether,
97:3). Yield 0.980 g (93%). M.p. 188–189 °C. Rf = 0.42 (CHCl3/
1
Et2O, 95:5). H NMR (300 MHz, CDCl3, 20 °C): δ = 8.87 (d, J =
1.8 Hz, 2 H, HAr), 8.13 (d, J = 8.1 Hz, 2 H, HAr), 7.95 (dd, J =
8.1, 1.8 Hz, 2 H, HAr), 7.09 (s, 2 H, HAr), 4.04 (s, 6 H, CH3), 3.98
(s, 6 H, CH3) ppm. 13C NMR (300 MHz, CDCl3, 20 °C): δ = 165.3
(CO2), 152.0 (CAr), 150.1 (CAr), 146.3 (CAr), 139.1 (CAr), 124.8
(CAr), 124.0 (CAr), 118.1 (CAr), 114.3 (CAr), 94.4 (CϵC), 88.8
(CϵC), 56.3 (OCH ), 53.3 (CO CH ) ppm. FTIR (KBr): ν = 2947
˜
3
2
3
(m) [ν(C–H)]; 2205 (s) [ν(CϵC)]; 1742 (s), 1720 (s) [ν(C=O)] cm–1.
ESI-MS (MeOH): calcd. for [M + Na]+ 479.1; found 479.0.
4,5-Bis[2-(2Ј-carboxybiphenyl-4-yl)ethynyl]veratrole Disodium Salt,
DEV(biphCO2Na)2 (6c): A reaction mixture containing DEV-
(biphCO2Me)2 (6a) (200 mg, 0.33 mmol) and sodium trimethylsil-
anolate (93.0 mg, 0.82 mmol) in THF (50 mL) was stirred at 60 °C
for 3 d. After cooling to room temperature, diethyl ether (70 mL)
was added to the resulting suspension, and the mixture was stirred
at room temperature for an additional 1 h. The white product was
filtered off, washed with diethyl ether, and dried under vacuum at
4,5-Bis{2-[8-(ethoxycarbonyl)quinol-3-yl]ethynyl}veratrole,
DEV(quinolineCO2Et)2 (9): A portion of [PdCl2(PPh3)2] (0.14 g,
10 mol-%) and CuI (19 mg, 5 mol-%) were added to a deoxy-
genated solution of 4,5-diethynylveratrole (1) (0.370 g, 1.97 mmol)
and ethyl 3-[(trifluoromethyl)sulfonyl]quinoline-8-carboxylate
(1.51 g, 4.32 mmol) in Et3N (5.0 mL) and THF (25 mL). The reac-
tion mixture was stirred at room temperature overnight. CH2Cl2
(150 mL) was added to the reaction mixture, which was washed
with aq. NH4Cl (100 mL). The organic phase was dried with
Na2SO4, filtered, and stripped to dryness. The product was purified
by column chromatography (CH2Cl2/diethyl ether, 95:5). Yield
0.920 g (80%). M.p. 168–169 °C. Rf = 0.45 (CHCl3/Et2O, 95:5). 1H
NMR (300 MHz, CDCl3, 20 °C): δ = 9.18 (d, J = 2.1 Hz, 2 H,
HAr), 8.34 (d, J = 1.8 Hz, 2 H, HAr), 8.04 (dd, J = 8.1, 1.2 Hz, 2
H, HAr), 7.88 (dd, J = 7.2, 1.2 Hz, 2 H, HAr), 7.59 (t, J = 7.8 Hz,
2 H, HAr), 7.13 (s, 2 H, HAr), 4.55 (q, J = 6.9 Hz, 4 H, CH2), 4.00
(s, 6 H, OCH3), 1.46 (t, J = 7.2 Hz, 6 H, CH2CH3) ppm. 13C NMR
(500 MHz, CDCl3, 20 °C): δ = 167.6 (CO2), 153.0 (CAr), 149.9
(CAr), 144.2 (CAr), 138.5 (CAr), 132.1 (CAr), 131.2 (CAr), 131.0
(CAr), 127.7 (CAr), 126.7 (CAr), 118.5 (CAr), 118.3 (CAr), 114.4
(CAr), 92.2 (CϵC), 89.6 (CϵC), 61.9 (CO2CH2), 56.4 (OCH3),
1
room temperature. Yield 190 mg (92%). M.p. Ͼ300 °C. H NMR
(300 MHz, [D6]DMSO, 20 °C): δ = 7.61–7.49 (m, 8 H, HAr), 7.34
(m, 2 H, HAr), 7.26 (m, 6 H, HAr), 7.19 (s, 2 H, HAr), 3.86 (s, 6 H,
OCH3) ppm. 13C NMR (500 MHz, [D6]DMSO, 20 °C): δ = 174.2
(CO2), 149.2 (CAr), 143.5 (CAr), 142.5 (CAr), 136.4 (CAr), 130.6
(CAr), 128.9 (CAr), 128.8 (CAr), 127.3 (CAr), 126.8 (CAr), 126.6
(CAr), 120.4 (CAr), 118.1 (CAr), 114.0 (CAr), 92.5 (CϵC), 88.7
(CϵC), 55.8 (OCH ) ppm. FTIR (KBr): ν = 2960 (w) [ν(C–H)];
˜
3
2208 (w) [ν(CϵC)]; 1600 (s), 1578 (s), 1562 (s) [ν(C=O)] cm–1. ESI-
MS (MeOH): calcd. for [M – Na]– 599.1; found 599.0; calcd. for
[M – 2 Na + H]– 577.2; found 577.2.
4,5-Bis{2-[2Ј-(methoxycarbonyl)-m-terphenyl-4-yl]ethynyl}veratrole,
DEV(terCO2Me)2 (7): Solid [Pd(PPh3)4] (0.040 g, 10 mol-%) was
added to a solution of 4,5-diethynylveratrole (1) (0.063 g,
0.34 mmol) and 3 (0.25 g, 0.68 mmol) in Et3N (0.50 mL) and THF
(15 mL) in a sealed pressure vessel inside a dry box. The yellow
solution was heated at 70 °C for ca. 36 h. After cooling to room
temperature, CH2Cl2 (30 mL) was added to the very dark orange
reaction mixture, which contained a white precipitate, presumably
(Et3NH)Br. After washing with aq. NH4Cl (2ϫ25 mL), the or-
ganic phase was dried with MgSO4, filtered, and concentrated to
dryness. The product was purified by column chromatography
(CH2Cl2/hexanes, 28:12). Yield 0.22 g (9%). Rf = 0.58 (CH2Cl2).
14.56 (CH CH ) ppm. FTIR (KBr): ν = 2981 (w), 2960 (m), 2937
˜
2
3
(w), 2902 (w) [ν(C–H)]; 2209 (m) [ν(CϵC)]; 1731 (s) [ν(C=O)] cm–1.
ESI-MS (MeOH): calcd. for [M + Na]+ 607.2; found 607.2.
Acknowledgments
This work was supported by the National Institute of General
Medical Sciences (grant GM032134). E. R. is the recipient of a
1H NMR (300 MHz, CDCl3, 20 °C): δ = 7.64–7.61 (m, 4 H, HAr), Schrödinger fellowship (J2485-B10) from the Austrian Science
162
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 156–163